117 related articles for article (PubMed ID: 16273656)
21. Sarcomatoid variant of anaplastic large cell lymphoma with cytoplasmic ALK and alpha-smooth muscle actin expression: a mimic of inflammatory myofibroblastic tumor.
Suzuki R; Seto M; Nakamura S; Nakagawa A; Hara K; Takeuchi K
Am J Pathol; 2001 Jul; 159(1):383-4. PubMed ID: 11438487
[No Abstract] [Full Text] [Related]
22. p53 gene mutations are uncommon but p53 is commonly expressed in anaplastic large-cell lymphoma.
Rassidakis GZ; Thomaides A; Wang S; Jiang Y; Fourtouna A; Lai R; Medeiros LJ
Leukemia; 2005 Sep; 19(9):1663-9. PubMed ID: 15990866
[TBL] [Abstract][Full Text] [Related]
23. Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma.
Schlette EJ; Medeiros LJ; Goy A; Lai R; Rassidakis GZ
J Clin Oncol; 2004 May; 22(9):1682-8. PubMed ID: 15117990
[TBL] [Abstract][Full Text] [Related]
24. The t(2;5) in human lymphomas.
Kadin ME; Morris SW
Leuk Lymphoma; 1998 Apr; 29(3-4):249-56. PubMed ID: 9684923
[TBL] [Abstract][Full Text] [Related]
25. Anaplastic large cell lymphoma of the pancreas: a pediatric case and literature review.
Fraser CJ; Chan YF; Heath JA
J Pediatr Hematol Oncol; 2004 Dec; 26(12):840-2. PubMed ID: 15591909
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of cyclin D3 in ALK+ and ALK- anaplastic large cell lymphoma.
Dalton RR; Rassidakis GZ; Atwell C; Wang S; Oyarzo MP; Medeiros LJ
Hum Pathol; 2005 Jul; 36(7):806-11. PubMed ID: 16084951
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage.
Rassidakis GZ; Sarris AH; Herling M; Ford RJ; Cabanillas F; McDonnell TJ; Medeiros LJ
Am J Pathol; 2001 Aug; 159(2):527-35. PubMed ID: 11485911
[TBL] [Abstract][Full Text] [Related]
28. [A case of the primary pancreatic lymphoma].
Hirabayashi K; Kawakami H; Aizawa T; Maeda M; Koike H; Maeda T; Itoh N
Rinsho Ketsueki; 1991 Apr; 32(4):414-8. PubMed ID: 2067088
[TBL] [Abstract][Full Text] [Related]
29. Anaplastic large cell lymphoma, ALK-negative.
Ferreri AJ; Govi S; Pileri SA; Savage KJ
Crit Rev Oncol Hematol; 2013 Feb; 85(2):206-15. PubMed ID: 22789917
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous presentation on the eyelid of primary, systemic, CD30+, anaplastic lymphoma kinase (ALK)-negative, anaplastic large-cell lymphoma (ALCL).
Mencía-Gutiérrez E; Gutiérrez-Díaz E; Salamanca J; Martínez-González MA
Int J Dermatol; 2006 Jun; 45(6):766-9. PubMed ID: 16796648
[TBL] [Abstract][Full Text] [Related]
31. ALK-positive anaplastic large cell lymphoma in a patient with chronic lymphocytic leukemia.
Liu T; He M; Carlson DL; Hedvat C; Teruya-Feldstein J
Int J Surg Pathol; 2010 Oct; 18(5):424-8. PubMed ID: 18794171
[TBL] [Abstract][Full Text] [Related]
32. Genomic DNA amplification and the detection of t(2;5)(p23;q35) in lymphoid neoplasms.
Sarris AH; Luthra R; Cabanillas F; Morris SW; Pugh WC
Leuk Lymphoma; 1998 May; 29(5-6):507-14. PubMed ID: 9643564
[TBL] [Abstract][Full Text] [Related]
33. Signal transducer and activator of transcription-3 activation contributes to high tissue inhibitor of metalloproteinase-1 expression in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
Lai R; Rassidakis GZ; Medeiros LJ; Ramdas L; Goy AH; Cutler C; Fujio Y; Kunisada K; Amin HM; Gilles F
Am J Pathol; 2004 Jun; 164(6):2251-8. PubMed ID: 15161657
[TBL] [Abstract][Full Text] [Related]
34. Jak3 activation is significantly associated with ALK expression in anaplastic large cell lymphoma.
Lai R; Rassidakis GZ; Lin Q; Atwell C; Medeiros LJ; Amin HM
Hum Pathol; 2005 Sep; 36(9):939-44. PubMed ID: 16153455
[TBL] [Abstract][Full Text] [Related]
35. [Anaplastic lymphoma kinase gene abnormality and the expression of its fusion protein in primary systemic anaplastic large cell lymphoma].
Shi YF; Liu CL; Zhou CJ; Gong LP; Dong LN; Li M; Huang X; Gao ZF
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):380-6. PubMed ID: 18677384
[TBL] [Abstract][Full Text] [Related]
36. Anaplastic lymphoma kinase-positive large B-cell lymphoma: description of a case with an unexpected clinical outcome.
Zanelli M; Valli R; Capodanno I; Ragazzi M; Ascani S
Int J Surg Pathol; 2015 Feb; 23(1):78-83. PubMed ID: 24868005
[TBL] [Abstract][Full Text] [Related]
37. Silibinin suppresses NPM-ALK, potently induces apoptosis and enhances chemosensitivity in ALK-positive anaplastic large cell lymphoma.
Molavi O; Samadi N; Wu C; Lavasanifar A; Lai R
Leuk Lymphoma; 2016 May; 57(5):1154-62. PubMed ID: 26133723
[TBL] [Abstract][Full Text] [Related]
38. A case of primary cutaneous anaplastic large cell lymphoma with variant anaplastic lymphoma kinase translocation.
Sasaki K; Sugaya M; Fujita H; Takeuchi K; Torii H; Asahina A; Tamaki K
Br J Dermatol; 2004 Jun; 150(6):1202-7. PubMed ID: 15214912
[TBL] [Abstract][Full Text] [Related]
39. Primary ALK-Positive Large B Cell Lymphoma of Pancreas.
Kushwaha P; Singh M; Vindal A; Verma N; Jain S
J Gastrointest Cancer; 2022 Sep; 53(3):830-833. PubMed ID: 34374890
[TBL] [Abstract][Full Text] [Related]
40. Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma.
Amin HM; McDonnell TJ; Ma Y; Lin Q; Fujio Y; Kunisada K; Leventaki V; Das P; Rassidakis GZ; Cutler C; Medeiros LJ; Lai R
Oncogene; 2004 Jul; 23(32):5426-34. PubMed ID: 15184887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]